Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR), an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV), today announced that Dr. Mark J. Murray, Tekmira's President and CEO, will present a corporate update at the JMP Securities Life Sciences Conference on Wednesday, June 24, 2015 at 11.00am - 11.30am (PT) / 2.00 - 2.30pm (ET) in New York.